Goldman Sachs’s Hologic HOLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
-51,100
| Closed | -$3.45M | – | 6592 |
|
|
2025
Q3 | $3.45M | Buy |
+51,100
| New | +$3.39M | ﹤0.01% | 3993 |
|
|
2018
Q1 | – | Sell |
-21,000
| Closed | -$898K | – | 6094 |
|
|
2017
Q4 | $898K | Buy |
21,000
+5,400
| +35% | +$215K | ﹤0.01% | 4405 |
|
|
2017
Q3 | $572K | Buy |
15,600
+14,300
| +1,100% | +$577K | ﹤0.01% | 5003 |
|
|
2017
Q2 | $59K | Sell |
1,300
-37,800
| -97% | -$1.67M | ﹤0.01% | 6318 |
|
|
2017
Q1 | $1.66M | Buy |
39,100
+1,000
| +3% | +$40.8K | ﹤0.01% | 3934 |
|
|
2016
Q4 | $1.53M | Buy |
38,100
+27,600
| +263% | +$1.07M | ﹤0.01% | 4095 |
|
|
2016
Q3 | $407K | Buy |
10,500
+5,300
| +102% | +$200K | ﹤0.01% | 5228 |
|
|
2016
Q2 | $180K | Sell |
5,200
-2,700
| -34% | -$93.5K | ﹤0.01% | 5776 |
|
|
2016
Q1 | $273K | Sell |
7,900
-78,700
| -91% | -$2.74M | ﹤0.01% | 5350 |
|
|
2015
Q4 | $3.35M | Sell |
86,600
-91,700
| -51% | -$3.57M | ﹤0.01% | 3186 |
|
|
2015
Q3 | $6.98M | Buy |
178,300
+111,700
| +168% | +$4.43M | ﹤0.01% | 2574 |
|
|
2015
Q2 | $2.54M | Sell |
66,600
-148,100
| -69% | -$5.18M | ﹤0.01% | 3598 |
|
|
2015
Q1 | $7.09M | Buy |
214,700
+177,900
| +483% | +$5.46M | ﹤0.01% | 2578 |
|
|
2014
Q4 | $984K | Buy |
36,800
+16,500
| +81% | +$426K | ﹤0.01% | 4577 |
|
|
2014
Q3 | $494K | Sell |
20,300
-483,000
| -96% | -$12.2M | ﹤0.01% | 5277 |
|
|
2014
Q2 | $12.8M | Buy |
503,300
+336,000
| +201% | +$7.85M | ﹤0.01% | 2176 |
|
|
2014
Q1 | $3.6M | Buy |
167,300
+61,600
| +58% | +$1.33M | ﹤0.01% | 3404 |
|
|
2013
Q4 | $2.36M | Sell |
105,700
-499,800
| -83% | -$11M | ﹤0.01% | 3905 |
|
|
2013
Q3 | $12.5M | Buy |
605,500
+429,700
| +244% | +$9.15M | ﹤0.01% | 2022 |
|
|
2013
Q2 | $3.39M | Buy |
+175,800
| New | +$3.67M | ﹤0.01% | 3147 |
|
Other funds holding HOLX
Goldman Sachs's HOLX Position: Q2 2026 in Review
Goldman Sachs sold out of Hologic (HOLX) in Q2 2026, closing a stake of 2,322,673 shares — an estimated $176M sold.
Goldman Sachs first reported a position in HOLX in Q2 2013 and held it in 52 quarters. The position peaked at $253M in Q1 2021. 3 funds tracked by Wall St. Rank hold HOLX as of Q2 2026.
- Goldman Sachs reported no remaining Hologic position as of Q2 2026 after selling out during the quarter.
- Goldman Sachs sold 2,322,673 Hologic shares in Q2 2026, an estimated $176M.
- Goldman Sachs first reported a position in Hologic in Q2 2013 and held it in 52 quarters.
- Goldman Sachs's Hologic position peaked at $253M in Q1 2021.
- 3 funds tracked by Wall St. Rank held Hologic as of Q2 2026.
Based on Goldman Sachs's 13F filing for Q2 2026, filed 14 Aug 2026.